Hepatology
Latest News
Thyroid Hormone Balance Crucial for Liver Fat Reduction
Participants who maintained higher tri-iodothyronine levels during the dietary intervention experienced a greater reduction in liver fat content...
From the Journals
Treatable Condition Misdiagnosed as Dementia in Almost 13% of Cases
“The potential for overlap between hepatic encephalopathy and dementia has risen and should be considered in the differential diagnosis.”
Latest News
Most Potentially Hepatotoxic Meds Revealed: Real-World Data Analysis
Patients initiating a medication with a high rate of severe acute liver injury might require closer monitoring of liver-related laboratory tests...
From the Journals
Combination Therapy Looks Promising for Hepatitis D
The combination resulted in higher rates of HDV RNA suppression levels at 24 weeks after end of treatment, especially at a higher, 10-mg dose of...
Conference Coverage
Significant Benefit with Liver Transplantation in ACLF: CHANCE Study
The findings highlight “the inadequacy of current transplant allocation criteria for patients with ACLF 2 and 3,” said Dr. Rajiv Jalan.
Conference Coverage
‘Dramatic’ Phase 2 Results for Survodutide in MASH, Fibrosis
Fifty percent of patients on 2.4- and 6-mg doses experienced a statistically significant improvement in fibrosis without worsening of MASH.
Conference Coverage
Seladelpar Shows Clinically Meaningful Improvements in PBC
The 2-year analysis also showed that seladelpar, a first-in-class, orally active agent, was safe and well tolerated.
Conference Coverage
Tirzepatide Shows Improvements in MASH Resolution, Fibrosis
Tirzepatide also led to weight loss in patients.
Commentary
Facial Temperature Can Reveal Age and Disease
Research points to use of facial temperature to determine age, health, diet, and sleep, says physician.
Latest News
Sex Hormones Linked to Fatty Liver in Men With T2D
Higher progesterone levels were associated with higher risk, whereas higher follicle-stimulating hormone was associted with lower risk.
Conference Coverage
Women with Autoimmune Liver Diseases Still Face Increased CVD Risks
Women with autoimmune hepatitis had a significantly higher cardiovascular risk compared to women without autoimmune hepatitis.